Loading...
Loading...
- LifeMD Inc LFMD reported Q1 adjusted EPS loss of $(0.38) better than the consensus loss of $(0.67).
- Revenue increased 323% Y/Y to a record $18.2 million in line with the consensus, primarily driven by a 349% increase in telemedicine product revenues.
- Total Telehealth Orders increased 373% Y/Y to 164 thousand.
- The company's LegalSimpli subsidiary, a PDF software-as-a-service, contributed $4.9 million in net sales, up 264% Y/Y.
- The gross margin expanded to 82% from 69% last year, attributable to lower product costs, growth of the prescription business, and inventory management.
- Adjusted EBITDA loss of $8.9 million compared to a loss of $556 thousand in the year-ago quarter.
- Cash balance for the quarter totaled $13.4 million.
- Guidance: For FY21, the company is raising its revenue guidance to $90 million and $100 million from its previous guidance of $85 and $95 million, exceeding the consensus of $87.8 million
- Price Action: LFMD shares are up 14.9% at 7.48 during the premarket session on the last check Friday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in